LaViolette, current Co-Chairman of the Board, as Chief Executive Officer. "We are thrilled to have Paul assume the role of Chief Executive Officer," said Pulse Biosciences’ Co-Chairman of the ...

Pulse Biosciences (PLSE) announced the appointment of Paul LaViolette, current co-chairman of the board, as CEO. LaViolette is currently a director for Edwards Lifesciences (EW) and chairman of ...

(RTTNews) - Novel bioelectric medicine company Pulse Biosciences, Inc. (PLSE) announced Friday the appointment of Paul LaViolette, current Co-Chairman of the Board, as Chief Executive Officer.

Pulse Biosciences has appointed the company's co-chairman, Paul A. LaViolette, as its new chief executive. LaViolette replaces Burke T. Barrett, who was named president and CEO of the medical ...

MIAMI - Pulse Biosciences, Inc. (NASDAQ:PLSE), a bioelectric medicine company with a market capitalization of $1.13 billion, has appointed Paul A. LaViolette as Chief Executive Officer ...

LaViolette, current Co-Chairman of the Board, as Chief Executive Officer. "We are thrilled to have Paul assume the role of Chief Executive Officer," said Pulse Biosciences’ Co-Chairman ...

Pulse Biosciences today announced feasibility study data supporting its Nanosecond PFA 360° cardiac catheter system.